Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Accumulated Depreciation & Amortization (2016 - 2026)

Usana Health Sciences has reported Accumulated Depreciation & Amortization over the past 13 years, most recently at $32.6 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 123.96% to $32.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $32.6 million through Jan 2026, up 123.96% year-over-year, with the annual reading at $32.6 million for FY2026, 123.96% up from the prior year.
  • Accumulated Depreciation & Amortization was $32.6 million for Q1 2026 at Usana Health Sciences, up from $14.5 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $32.6 million in Q1 2026 and troughed at $12.7 million in Q4 2023.
  • The 4-year median for Accumulated Depreciation & Amortization is $13.4 million (2022), against an average of $17.2 million.
  • Year-over-year, Accumulated Depreciation & Amortization fell 5.17% in 2022 and then skyrocketed 123.96% in 2026.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $13.4 million in 2022, then fell by 5.16% to $12.7 million in 2023, then increased by 14.46% to $14.5 million in 2024, then surged by 123.96% to $32.6 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Accumulated Depreciation & Amortization are $32.6 million (Q1 2026), $14.5 million (Q4 2024), and $12.7 million (Q4 2023).